PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
229 hedge funds and large institutions have $4.07B invested in PRA Health Sciences, Inc. in 2017 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 89 increasing their positions, 59 reducing their positions, and 17 closing their positions.
282% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 17
51% more repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 59
21% more funds holding
Funds holding: 189 → 229 (+40)
21% more capital invested
Capital invested by funds: $3.37B → $4.07B (+$702M)
1.7% more ownership
Funds ownership: 99.49% → 101.19% (+1.7%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
90% less call options, than puts
Call options by funds: $1.09M | Put options by funds: $10.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$168M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$30.6M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$27.4M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$25.3M |
| 5 |
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Chicago,
Illinois
|
+$18.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$72.9M |
| 2 |
Morgan Stanley
New York
|
-$43.7M |
| 3 |
SC
Samlyn Capital
New York
|
-$43.3M |
| 4 |
LCM
Laurion Capital Management
New York
|
-$35.4M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$33.1M |
PRAH Hedge Fund Activity: Q1 2017 in Review
229 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q1 2017, worth a combined $4.07B — up 21% from $3.37B a quarter earlier.
Buyers outnumbered sellers: 65 funds opened new PRAH positions and 17 closed out — a net gain of 48 holders — while 89 added to existing stakes and 59 trimmed.
The largest buyer was BlackRock, adding an estimated $168M. The largest seller was Marshall Wace, cutting an estimated $72.9M.
- 229 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q1 2017, up from 189 in Q4 2016.
- Funds reported $4.07B of PRA Health Sciences, Inc. stock for Q1 2017, up 21% quarter-over-quarter.
- 65 funds opened new PRA Health Sciences, Inc. positions in Q1 2017 and 17 closed out, a net change of +48 holders.
- The largest PRA Health Sciences, Inc. buyer in Q1 2017 was BlackRock, an estimated $168M added.
- The largest PRA Health Sciences, Inc. seller in Q1 2017 was Marshall Wace, an estimated $72.9M sold.
Based on aggregated 13F filings for Q1 2017.